妇婴疾病诊断相关组应用与评价  

The Applications and Evaluation on Wemen and Infant's Diagnosis-related Groups

作　　者：魏凌云[1] 韩栋[1] 徐金龙[1] 章莹[1] 

机构地区：[1]广东省妇幼保健院,广州510010

出　　处：《中国卫生经济》2016年第5期81-83,共3页Chinese Health Economics

基　　金：广东省自然科学基金项目(S2012010008269)

摘　　要：目的：探讨妇婴疾病诊断相关组模型的分组效果和应用评价。方法：比较分析WI-DRGs模型的组内同质性和组间异质性。比较分析WI-DRGs、CN-DRGs、MS-DRGS和AR-DRGs的分组效果,比较三个独立院区CMI指数以评价其应用效果。结果：WI-DRGs费用RIV为0.596,CV为0.10-0.54,平均住院日RIV为0.389,CV为0.02-0.22。WI-DRGs在妇婴疾病分组方面较优。结论：WI-DRGs组间异质性和组内同质性较好,具有较好的实用性,在控制费用增长,优化费用结构,尤其是提升妇幼卫生经费使用效率方面具有较广泛的应用前景。Objective：To discuss the grouping effect and application evaluation of Women Infant-Diagnosis-RelatedGroups（WI-DRGs） model.Methods：The homogeneity within groups and heterogeneity among groups of WI-DRGs were evaluated.The grouping effects of WI-DRGs, CN-DRGs, MS-DRGs and AR-DRGs were compared. The CMI of three districts were compared toverify the application effects.Results：The cost RIV and CV of WI-DRGs were 0.596 and 0.10-0.54, length of stay RIV and CV were0.389 and 0.02-0.22. WI-DRGs were the preferred in grouping of wemen＇s and infants＇ disease.Conclusion：The heterogeneityamong groups and the homogeneity within groups were sound in the WI-DRGs system. WI-DRGs could be applied comprehensivelyin controlling the cost growth, optimizing cost structure, especially had extensive application prospect of promoting the usage efficiencyof maternal and child healthcare expenditure.

关 键 词：妇婴疾病诊断相关组 比较分析 医疗保险 

分 类 号：R1[医药卫生—公共卫生与预防医学]